4
Dear Colleague, We are pleased to invite you to a very exciting and intensive accredited educational activity designed specifically for physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and discuss the impact of clinical comorbidities such as nutritional deficits and mental health issues. We will also interview a patient with cystic fibrosis and then collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help our patients improve their adherence to treatment. This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. Please plan to register soon. We look forward to seeing you! Matthias A. Salathe, MD Program Chairman Peter J. Mogayzel, Jr., MD, PhD Professor of Pediatrics Director, Cystic Fibrosis Center Johns Hopkins School of Medicine Baltimore, MD Carlos E. Milla, MD Associate Professor of Pediatrics – Pulmonary Medicine Director, The Stanford Cystic Fibrosis Center Associate Director for Translational Research Center for Excellence in Pulmonary Biology Stanford University School of Medicine Palo Alto, CA FORT LAUDERDALE CYSTIC FIBROSIS SUMMIT CURRENT TRENDS AND FUTURE DIRECTIONS Matthias A. Salathe, MD Program Chairman Professor of Medicine Chief, Division of Pulmonary & Critical Care Medicine University of Miami School of Medicine Director, Adult Cystic Fibrosis Center University of Miami Miami, FL

FIBROSIS FUTURE DIRECTIONS CURRENT TRENDS AND …mosbrookdesign.com/ABcomm/CFFlorida/CFFlorida.pdf · SUMMIT FUTURE DIRECTIONS JERSEY CITY CYSTIC FIBROSIS CURRENT TRENDS AND SUMMIT

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: FIBROSIS FUTURE DIRECTIONS CURRENT TRENDS AND …mosbrookdesign.com/ABcomm/CFFlorida/CFFlorida.pdf · SUMMIT FUTURE DIRECTIONS JERSEY CITY CYSTIC FIBROSIS CURRENT TRENDS AND SUMMIT

ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Supported by an independent educational grant from Gilead Sciences Medical Affairs.

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Provided by ABcomm, Inc.

Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate DriveFort Lauderdale, FL

OCT

14

Saturday, October 14, 20178:00 am – 2:30 pmThe Westin Fort Lauderdale 400 Corporate DriveFort Lauderdale, FL

Dear Colleague,

We are pleased to invite you to a very exciting and intensive accredited educational activity designed specifically for physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and discuss the impact of clinical comorbidities such as nutritional deficits and mental health issues.

We will also interview a patient with cystic fibrosis and then collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help our patients improve their adherence to treatment.

This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. Please plan to register soon. We look forward to seeing you!

Matthias A. Salathe, MDProgram Chairman

Peter J. Mogayzel, Jr., MD, PhDProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD

Carlos E. Milla, MDAssociate Professor of Pediatrics – Pulmonary MedicineDirector, The Stanford Cystic Fibrosis CenterAssociate Director for Translational ResearchCenter for Excellence in Pulmonary BiologyStanford University School of MedicinePalo Alto, CA

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

ITSAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Matthias A. Salathe, MDProgram ChairmanProfessor of MedicineChief, Division of Pulmonary & Critical Care MedicineUniversity of Miami School of MedicineDirector, Adult Cystic Fibrosis CenterUniversity of MiamiMiami, FL

Page 2: FIBROSIS FUTURE DIRECTIONS CURRENT TRENDS AND …mosbrookdesign.com/ABcomm/CFFlorida/CFFlorida.pdf · SUMMIT FUTURE DIRECTIONS JERSEY CITY CYSTIC FIBROSIS CURRENT TRENDS AND SUMMIT

PROGRAM AGENDA

8:00 am – 8:30 am CME Registration / Continental Breakfast

8:30 am – 8:45 am Welcome and Introductions Matthias A. Salathe, MD

8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview

9:30 am – 10:00 am The Current Lay of the Land Matthias A. Salathe, MD

10:00 am – 10:15 am Break

10:15 am – 11:15 am The Big Picture – Infection Prevention to Chronic Suppression

Peter J. Mogayzel, Jr., MD, PhD

11:15 am – 12:00 pm CFTR Modulation – Where We Are and Where We Are Headed

Carlos E. Milla, MD

12:00 pm – 1:15 pm Lunch / Breakout Session All Faculty

1:15 pm – 1:45 pm Pediatric to Adult Care – Easing the Transition Carlos E. Milla, MD

1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success

Peter J. Mogayzel, Jr., MD, PhD

2:15 pm – 2:30 pm Concluding Remarks and Evaluation Matthias A. Salathe, MD

LEARNING OBJECTIVESAs a result of attending this activity, participants will be able to: Describe the clinical relevance and changing epidemiology of

consequential respiratory pathogens. Select aerosolized antibiotics by comparing safety, efficacy, and

long-term study data, and monitor outcomes for necessary treatment adjustments.

Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.

Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.

Outline current recommendations for transfer from the pediatric to the adult care setting.

Appreciate the number and complexity of treatments, and involve patients and/or family in treatment management decisions to improve adherence.

ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATIONABcomm, Inc. designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an activity evaluation form in order to receive a certificate of credit. Certificates will be mailed to participants 4-6 weeks after the activity.

Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate Drive Fort Lauderdale, FL

DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities. This information will be made available to participants at the beginning of the activity.

REGISTRATION PROCEDURE Registrations will be accepted through Friday, October 6, 2017 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.

Registrations can be submitted using one of the following methods:

ONLINE: Go to www.cfsummitfortlauderdale.eventbrite.com

TELEPHONE: Contact us at (217) 607-1285 during regular business hours.

FAX / SCAN: Complete the written application form and email to [email protected] or fax to (866) 266-9741.

MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.

FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.

REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by October 6, 2017.

LODGINGThe Westin Fort Lauderdale400 Corporate DriveFort Lauderdale, FL 33334(954) 772-1331

Free parking is available.

OTHER INFORMATION

WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER

ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE

ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER WEEK?

HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE

WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?

IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:

IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:

FIRST NAME LAST NAME DEGREE(S)

TITLE INSTITUTION

ADDRESS CITY STATE

ZIP PHONE EMAIL

PAYMENT INFORMATION

Visa MasterCard American Express Discover Check (mailed with registration form)

CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE

BILLING ADDRESS

REGISTRATION FORM

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

REGISTRATION DEADLINE: FRIDAY, OCTOBER 6, 2017

Register online at www.cfsummitfortlauderdale.eventbrite.com

REGISTER ONLINE ATwww.cfsummitfortlauderdale.eventbrite.com

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Page 3: FIBROSIS FUTURE DIRECTIONS CURRENT TRENDS AND …mosbrookdesign.com/ABcomm/CFFlorida/CFFlorida.pdf · SUMMIT FUTURE DIRECTIONS JERSEY CITY CYSTIC FIBROSIS CURRENT TRENDS AND SUMMIT

PROGRAM AGENDA

8:00 am – 8:30 am CME Registration / Continental Breakfast

8:30 am – 8:45 am Welcome and Introductions Matthias A. Salathe, MD

8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview

9:30 am – 10:00 am The Current Lay of the Land Matthias A. Salathe, MD

10:00 am – 10:15 am Break

10:15 am – 11:15 am The Big Picture – Infection Prevention to Chronic Suppression

Peter J. Mogayzel, Jr., MD, PhD

11:15 am – 12:00 pm CFTR Modulation – Where We Are and Where We Are Headed

Carlos E. Milla, MD

12:00 pm – 1:15 pm Lunch / Breakout Session All Faculty

1:15 pm – 1:45 pm Pediatric to Adult Care – Easing the Transition Carlos E. Milla, MD

1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success

Peter J. Mogayzel, Jr., MD, PhD

2:15 pm – 2:30 pm Concluding Remarks and Evaluation Matthias A. Salathe, MD

LEARNING OBJECTIVESAs a result of attending this activity, participants will be able to: Describe the clinical relevance and changing epidemiology of

consequential respiratory pathogens. Select aerosolized antibiotics by comparing safety, efficacy, and

long-term study data, and monitor outcomes for necessary treatment adjustments.

Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.

Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.

Outline current recommendations for transfer from the pediatric to the adult care setting.

Appreciate the number and complexity of treatments, and involve patients and/or family in treatment management decisions to improve adherence.

ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATIONABcomm, Inc. designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an activity evaluation form in order to receive a certificate of credit. Certificates will be mailed to participants 4-6 weeks after the activity.

Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate Drive Fort Lauderdale, FL

DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities. This information will be made available to participants at the beginning of the activity.

REGISTRATION PROCEDURE Registrations will be accepted through Friday, October 6, 2017 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.

Registrations can be submitted using one of the following methods:

ONLINE: Go to www.cfsummitfortlauderdale.eventbrite.com

TELEPHONE: Contact us at (217) 607-1285 during regular business hours.

FAX / SCAN: Complete the written application form and email to [email protected] or fax to (866) 266-9741.

MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.

FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.

REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by October 6, 2017.

LODGINGThe Westin Fort Lauderdale400 Corporate DriveFort Lauderdale, FL 33334(954) 772-1331

Free parking is available.

OTHER INFORMATION

WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER

ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE

ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER WEEK?

HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE

WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?

IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:

IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:

FIRST NAME LAST NAME DEGREE(S)

TITLE INSTITUTION

ADDRESS CITY STATE

ZIP PHONE EMAIL

PAYMENT INFORMATION

Visa MasterCard American Express Discover Check (mailed with registration form)

CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE

BILLING ADDRESS

REGISTRATION FORM

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

REGISTRATION DEADLINE: FRIDAY, OCTOBER 6, 2017

Register online at www.cfsummitfortlauderdale.eventbrite.com

REGISTER ONLINE ATwww.cfsummitfortlauderdale.eventbrite.com

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Page 4: FIBROSIS FUTURE DIRECTIONS CURRENT TRENDS AND …mosbrookdesign.com/ABcomm/CFFlorida/CFFlorida.pdf · SUMMIT FUTURE DIRECTIONS JERSEY CITY CYSTIC FIBROSIS CURRENT TRENDS AND SUMMIT

ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Supported by an independent educational grant from Gilead Sciences Medical Affairs.

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Provided by ABcomm, Inc.

Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate DriveFort Lauderdale, FL

OCT

14

Saturday, October 14, 20178:00 am – 2:30 pmThe Westin Fort Lauderdale 400 Corporate DriveFort Lauderdale, FL

Dear Colleague,

We are pleased to invite you to a very exciting and intensive accredited educational activity designed specifically for physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and discuss the impact of clinical comorbidities such as nutritional deficits and mental health issues.

We will also interview a patient with cystic fibrosis and then collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help our patients improve their adherence to treatment.

This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. Please plan to register soon. We look forward to seeing you!

Matthias A. Salathe, MDProgram Chairman

Peter J. Mogayzel, Jr., MD, PhDProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD

Carlos E. Milla, MDAssociate Professor of Pediatrics – Pulmonary MedicineDirector, The Stanford Cystic Fibrosis CenterAssociate Director for Translational ResearchCenter for Excellence in Pulmonary BiologyStanford University School of MedicinePalo Alto, CA

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

FORT LAUDERDALE

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

JERSEY CITY

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

SAN FRANCISCO

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Matthias A. Salathe, MDProgram ChairmanProfessor of MedicineChief, Division of Pulmonary & Critical Care MedicineUniversity of Miami School of MedicineDirector, Adult Cystic Fibrosis CenterUniversity of MiamiMiami, FL